期刊： CANCER TREATMENT REVIEWS, 2021; 96 ()
Selective RET inhibitors is the current hot topic, making multikinase inhibitors a thing of the past. However, the limitation of various test approach......
期刊： CANCER TREATMENT REVIEWS, 2021; 95 ()
The mesenchymal-epithelial transition (MET) receptor tyrosine kinase binds the hepatocyte growth factor to activate downstream cell signaling pathways......
期刊： CANCER TREATMENT REVIEWS, 2020; 91 ()
Hyperprogressive disease (HPD) is a concerning paradoxical acceleration of cancer growth induced by immune drugs. The lack of standard radiological cr......
期刊： CANCER TREATMENT REVIEWS, 2020; 89 ()
To date, much progress has been made in early-stage extranodal NK/T-cell lymphoma (ENKTCL), and risk-adapted therapy with radiotherapy (RT) alone for ......
期刊： CANCER TREATMENT REVIEWS, 2020; 85 ()
Up to one in four patients with nasopharyngeal carcinoma present with non-metastatic stage IV disease (i.e. T4 or N3). Distinct failure patterns exist......
期刊： CANCER TREATMENT REVIEWS, 2020; 86 ()
In colorectal cancer (CRC), imaging is important in determining tumor stage, selecting treatment strategies, and in assessing response to therapy. How......
期刊： CANCER TREATMENT REVIEWS, 2020; 91 ()
Background: We aimed to explore whether cribriform and adenoid cystic carcinoma had comparable prognoses to mucinous, tubular and papillary carcinoma,......
期刊： CANCER TREATMENT REVIEWS, 2019; 74 ()
Immune checkpoint inhibitors-based immunotherapy offers a new effective modality in the treatment of advanced malignancies. Considering the remarkable......
期刊： CANCER TREATMENT REVIEWS, 2019; 75 ()
Background: One year of adjuvant trastuzumab treatment is the standard of care for early stage human epidermal growth factor receptor 2 (HER2)-positiv......
期刊： CANCER TREATMENT REVIEWS, 2019; 81 ()
The aberrant activation of RAS-derived mitogen-activated protein kinase (MAPK) signaling pathway plays a prominent role in tumorigenesis of an array o......
期刊： CANCER TREATMENT REVIEWS, 2019; 79 ()
As a consequence of the current excellent loco-regional control rates attained using the generally accepted treatment paradigms involving intensity-mo......
期刊： CANCER TREATMENT REVIEWS, 2019; 72 ()
Lung cancer still represents one of the most common and fatal neoplasm, accounting for nearly 30% of all cancer-related deaths. Targeted therapies bas......
期刊： CANCER TREATMENT REVIEWS, 2019; 78 ()
Human papillomavirus (HPV)-associated intraepithelial neoplasia or cancers are ideal candidates for cancer immunotherapy since HPV oncoproteins, such ......
期刊： CANCER TREATMENT REVIEWS, 2018; 70 ()
Objectives: The aim of this study was to investigate the quality of clinical practice guidelines of cancer cachexia and identify gaps limiting knowled......
期刊： CANCER TREATMENT REVIEWS, 2018; 62 ()
Sarcomas are rare and complex malignancies that have been associated with a poor prognostic outcome. Over the last few decades, traditional treatment ......
